Literature DB >> 23032167

Meningococcal serogroup Y emergence in Europe: update 2011.

Michael Bröker1, Susanne Jacobsson, Markku Kuusi, David Pace, Maria J Simões, Anna Skoczynska, Muhamed-Kheir Taha, Maija Toropainen, Georgina Tzanakaki.   

Abstract

Neisseria meningitidis is differentiated into 12 distinct serogroups, of which A, B, C, W-135, X, and Y are medically most important and represent an important health problem in different parts of the world. The epidemiology of N. meningitidis is unpredictable over time and across geographic regions. Recent epidemiological surveillance has indicated an increase of serogroup Y invasive meningococcal disease in some parts of Europe as shown in the epidemiological data for 2010 from various European countries previously published in this journal. ( 1) Here, data is reported indicating that the emergence of serogroup Y continued in 2011 in various regions of Europe. The average age of persons affected by N. meningitidis serogroup Y seems to have decreased in some countries in comparison to the previous decade.

Entities:  

Keywords:  Europe; epidemiology; meningococcal disease; serogroup Y; surveillance

Mesh:

Year:  2012        PMID: 23032167      PMCID: PMC3656084          DOI: 10.4161/hv.21794

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

1.  Quadrivalent meningococcal conjugated vaccine: a routine or selective vaccine in Europe?

Authors:  Cristina Masuet-Aumatell; Ray Borrow; Jane N Zuckerman
Journal:  J Infect       Date:  2012-04-25       Impact factor: 6.072

2.  The epidemiology of meningococcal disease in Norway 1975-91.

Authors:  A Lystad; S Aasen
Journal:  NIPH Ann       Date:  1991-12

3.  Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States.

Authors:  Ziad A Memish; Atef M Shibl
Journal:  Travel Med Infect Dis       Date:  2011-02-22       Impact factor: 6.211

Review 4.  Increase of meningococcal serogroup Y cases in Europe: a reason for concern?

Authors:  Michael Bröker; Susanne Jacobsson; Lisa DeTora; David Pace; Muhamed-Kheir Taha
Journal:  Hum Vaccin Immunother       Date:  2012-05-01       Impact factor: 3.452

Review 5.  Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.

Authors:  Marco A P Sáfadi; E David G McIntosh
Journal:  Expert Rev Vaccines       Date:  2011-12       Impact factor: 5.217

6.  Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.

Authors:  Lee H Harrison; Kathleen A Shutt; Susanna E Schmink; Jane W Marsh; Brian H Harcourt; Xin Wang; Anne M Whitney; David S Stephens; Amanda A Cohn; Nancy E Messonnier; Leonard W Mayer
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

Review 7.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

8.  Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.

Authors:  Peter C Richmond; Helen S Marshall; Michael D Nissen; Qin Jiang; Kathrin U Jansen; Maria Garcés-Sánchez; Federico Martinón-Torres; Johannes Beeslaar; Leszek Szenborn; Jacek Wysocki; Joseph Eiden; Shannon L Harris; Thomas R Jones; John L Perez
Journal:  Lancet Infect Dis       Date:  2012-05-07       Impact factor: 25.071

9.  Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States.

Authors:  Mary G Krauland; Julie C Dunning Hotopp; David R Riley; Sean C Daugherty; Jane W Marsh; Nancy E Messonnier; Leonard W Mayer; Hervé Tettelin; Lee H Harrison
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Serogroup Y meningococcal disease, Colombia.

Authors:  Clara Inés Agudelo; Olga Marina Sanabria; María Victoria Ovalle
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

View more
  12 in total

1.  Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013.

Authors:  Michael Bröker; Stéphane Emonet; Cecilia Fazio; Susanne Jacobsson; Maria Koliou; Markku Kuusi; David Pace; Metka Paragi; Alexander Pysik; Maria João Simões; Anna Skoczynska; Paola Stefanelli; Maija Toropainen; Muhamed-Kheir Taha; Georgina Tzanakaki
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Meningococcal serogroup Y emergence in Europe: high importance in some European regions in 2012.

Authors:  Michael Bröker; Suzana Bukovski; Davor Culic; Susanne Jacobsson; Maria Koliou; Markku Kuusi; Maria João Simões; Anna Skoczynska; Maija Toropainen; Muhamed-Keir Taha; Georgina Tzanakaki
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

Review 3.  Prevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infection.

Authors:  E David McIntosh; Victor Carey; Daniela Toneatto; Peter Dull; James Wassil
Journal:  Ther Adv Vaccines       Date:  2015-01

4.  Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.

Authors:  Josefien Cornelie Minthe Bousema; Joost Ruitenberg
Journal:  Int J Health Policy Manag       Date:  2015-09-13

Review 5.  Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review.

Authors:  Sohita Dhillon; David Pace
Journal:  Drugs       Date:  2017-11       Impact factor: 11.431

6.  Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012.

Authors:  Bianca Törös; Sara T Hedberg; Magnus Unemo; Susanne Jacobsson; Dorothea M C Hill; Per Olcén; Hans Fredlund; Holly B Bratcher; Keith A Jolley; Martin C J Maiden; Paula Mölling
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

7.  Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.

Authors:  Dorothea M C Hill; Jay Lucidarme; Stephen J Gray; Lynne S Newbold; Roisin Ure; Carina Brehony; Odile B Harrison; James E Bray; Keith A Jolley; Holly B Bratcher; Julian Parkhill; Christoph M Tang; Ray Borrow; Martin C J Maiden
Journal:  Lancet Infect Dis       Date:  2015-10-27       Impact factor: 25.071

8.  A decade of invasive meningococcal disease surveillance in Poland.

Authors:  Anna Skoczyńska; Izabela Waśko; Alicja Kuch; Marcin Kadłubowski; Agnieszka Gołębiewska; Małgorzata Foryś; Marlena Markowska; Patrycja Ronkiewicz; Katarzyna Wasiak; Aleksandra Kozińska; Bożena Matynia; Waleria Hryniewicz
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

9.  Implications of differential age distribution of disease-associated meningococcal lineages for vaccine development.

Authors:  Carina Brehony; Caroline L Trotter; Mary E Ramsay; Manosree Chandra; Keith A Jolley; Arie van der Ende; Françoise Carion; Lene Berthelsen; Steen Hoffmann; Hjördís Harðardóttir; Julio A Vazquez; Karen Murphy; Maija Toropainen; Manuela Caniça; Eugenia Ferreira; Mathew Diggle; Giles F Edwards; Muhamed-Kheir Taha; Paola Stefanelli; Paula Kriz; Steve J Gray; Andrew J Fox; Susanne Jacobsson; Heike Claus; Ulrich Vogel; Georgina Tzanakaki; Sigrid Heuberger; Dominique A Caugant; Matthias Frosch; Martin C J Maiden
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

10.  A High-Throughput Size Exclusion Chromatography Method to Determine the Molecular Size Distribution of Meningococcal Polysaccharide Vaccine.

Authors:  Imran Khan; K M Taufiqur Rahman; S M Saad Us Siraj; Mahbubul Karim; Abdul Muktadir; Arpan Maheshwari; Md Azizul Kabir; Zebun Nahar; Mohammad Mainul Ahasan
Journal:  Int J Anal Chem       Date:  2016-09-05       Impact factor: 1.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.